Home | About PR | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |   Login 
Pharmacognosy Magazine
Search Article 
Advanced search 
Year : 2021  |  Volume : 13  |  Issue : 2  |  Page : 96-103

Herbs and medications used for treatment and prophylaxis of influenza infections including H5N1, H1N1, SARS-CoV, and SARS-CoV-2

Clinical Pharmacy Specialist at Sameh Pharmacy, Cairo, Egypt; Former Hospital Pharmacist at Gizan General Hospital, KSA

Correspondence Address:
Dr. Sameh Monir Abdou Desouki
Clinical Pharmacy Specialist at Sameh Pharmacy, Cairo; Former Hospital Pharmacist at Gizan General Hospital

Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/pr.pr_32_20

Rights and Permissions

Background: Herbs are plants or plant parts used for their scent, flavor, or therapeutic properties. Herbal medicine is one type of dietary supplement that has been used for thousands of years for treatment or prophylaxis of many diseases including influenza virus infection. Although there are many previous studies about these issues, I did not find many research about using these herbs in treatment or prophylaxis of other influenza infections including H5N1, H1N1, severe acute respiratory syndrome coronavirus (SARS-CoV), and SARS-CoV-2. Objective: To collect, evaluate, and explore new important data about using medicinal herbs in these disorders' treatment or prophylaxis. Materials and Methods: I collected and explored new results and data from 24 professional health-care givers who had an experience about using these herbs in treatment or prophylaxis of these diseases. Then, I evaluated descriptively and quantitatively the results with alpha significance level ≤5% by tests such as Chi-square one-sample and reliability and validity tests. Results: The study showed many significant results about using these herbs, through using descriptive tests including one-sample Chi-square test, like in SARS-CoV-2 treatment (n = 414) with mean = 2.5870 ± 0.06730 and P < 0.05, while in SARS-CoV-2, prophylaxis (n = 275) with mean = 2.1164 ± 0.06271 and P < 0.05. Conclusion: This study revealed that there are some particular herbs that can be used in the treatment and prophylaxis of these diseases as adjunctives to the main typical treatment regimen, not as a monotherapy. Furthermore, many studies should be conducted in this field.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded197    
    Comments [Add]    

Recommend this journal